Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec;44(12):3425-7.
doi: 10.1128/AAC.44.12.3425-3427.2000.

Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin)

F M Aarestrup  1 , L B Jensen
Affiliations

Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin)

F M Aarestrup et al. Antimicrob Agents Chemother. 2000 Dec.

Abstract

Fragments (414 bp) of the gene-encoding ribosomal protein L16 from Enterococcus faecium and Enterococcus faecalis that were resistant and susceptible to the oligosaccharide antibiotics avilamycin and evernimicin (SCH 27899) were sequenced and compared. The susceptible E. faecalis and E. faecium isolates had sequences that were similar to those of the type strains. All resistant E. faecalis isolates contained the same base pair variation [CGT (Arg-56) --> CAT (His-56)]. The same variation and two additional variations [ATC (Ile-52) --> ACC (Thr-52) and ATC (Ile-52) --> AGC (Ser-52)] were found in the resistant E. faecium isolates. This study indicated that resistance to the oligosaccharides in enterococci is associated with variations in the ribosomal protein L16.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
L16 DNA sequence of Enterococcus faecalis and Enterococcus faecium (CCUG 542). Position of primers are indicated (bold and underlined). The variations observed are also indicated.
See this image and copyright information in PMC

References

    1. Aarestrup F M. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, evernimicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin. Microb Drug Resist. 1998;4:137–141. - PubMed
    1. Aarestrup F M, Bager F, Madsen M, Jensen N E, Meyling A, Wegener H C. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS. 1998;106:606–622. - PubMed
    1. Aarestrup F M, Bager F, Andersen J S. The association between the use of avilamycin for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs. Epidemiological study and changes over time. Microb Drug Resist. 2000;6:71–75. - PubMed
    1. Jensen L B, Ahrens P, Dons L, Jones R N, Hammerum A M, Aarestrup F M. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol. 1998;36:437–442. - PMC - PubMed
    1. Jones R N, Low D E, Pfaller M A. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds. Diagn Microbiol Infect Dis. 1999;33:101–112. - PubMed

Publication types

LinkOut - more resources